Peripheral amino Acid levels in schizophrenia and antipsychotic treatment
- PMID: 20046338
- PMCID: PMC2796006
- DOI: 10.4306/pi.2008.5.4.203
Peripheral amino Acid levels in schizophrenia and antipsychotic treatment
Abstract
Abnormal levels of amino acids have been reported in patients with schizophrenia and have also been investigated as a biomarker to monitor antipsychotic treatment, however results have been inconsistent. The purpose of the present review is to summarize the evidence in the literature of whether amino acid levels can be a biomarker and predict the treatment outcome in schizophrenia. The current review does not support amino acid concentration as a useful biomarker for monitoring antipsychotic response in patients with schizophrenia, although there is evidence that high levels of serum homocysteine and glutamate might be considered as a trait marker for schizophrenia. This review has also highlighted a considerable dearth of studies, specifically of studies evaluating antipsychotic side-effects.
Keywords: Amino acids; Antipsychotics; Neuroleptics; Schizophrenia.
References
-
- Fernstrom JD, Faller DV. Neutral amino acids in the brain: changes in response to food ingestion. J Neurochem. 1978;30:1531–1538. - PubMed
-
- Fernstrom JD. Dietary precursors and brain neurotransmitter formation. Annu Rev Med. 1981;32:413–425. - PubMed
-
- Maycox PR, Hell JW, Jahn R. Amino acid neurotransmission: spotlight on synaptic vesicles. Trends Neurosci. 1990;13:83–87. - PubMed
-
- Tortorella A, Monteleone P, Fabrazzo M, Viggiano A, De Luca L, Maj M. Plasma concentrations of amino acids in chronic schizophrenics treated with clozapine. Neuropsychobiology. 2001;44:167–171. - PubMed
-
- Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. . Psychopharmacology (Berl) 1989;99(Suppl):S18–S27. - PubMed
LinkOut - more resources
Full Text Sources
